Clinical Trials Based on CIRM Grants

CIRM has funded early-stage awards whose research has progressed into clinical trials. Below is a list of clinical trials that are a result of these early-stage CIRM-funded awards. For a list of CIRM-funded trials, visit our Funding Clinical Trials page.

Grantees Trial sponsor Disease Supporting Grant Trial details
Karen Aboody City of Hope Brain Cancer Disease Team Research I

Phase 1 NCT02192359

Martin Marsala Neuralstem Spinal Cord Injury Comprehensive Grant Phase 1 NCT01772810
Catriona Jamieson TargeGen/Sanofi Myelofibrosis Training
SEED

Phase 1
NCT00631462

Phase 1/2
NCT00724334

Catriona Jamieson Sanofi Polycythemia vera Training
SEED
New Faculty
 

Phase 2
NCT01420770

Phase 2
NCT01420783

Phase 2
NCT01523171

Phase 3
NCT01437787
CLOSED

Dennis Carson
Catriona Jamieson
John Dick
Pfizer Leukemia Disease Team

Phase 1
NCT00953758

Phase 1/2
NCT01546038

Joel Gottesfeld Repligen, Corp Ataxia Basic Biology Phase 1 Italy

Antoni Ribas
Zoran Galic

Jonsson Comprehensive Cancer Center Metastatic melanoma

SEED
New Faculty

Phase 2 NCT00910650

Katja Piltti
Aileen Anderson

Stem Cells, Inc Spinal cord injury Training Phase 1/2
NCT01321333
Stephen Forman City of Hope Glioblastoma Early Translation III Phase 1 NCT02208362
Antoni Ribas Jonsson Comprehensive Cancer Center Advanced malignancies New Faculty Phase 2 NCT01697527
Peter Coffey Pfizer Blindness Leadership Award Phase 1 NCT01691261